Best Peptides for Sexual Health & Libido
The peptides most studied for sexual health are PT-141 (bremelanotide), a melanocortin agonist researched for libido pathways in both sexes, and Kisspeptin, studied for reproductive-hormone signaling. Oxytocin is also researched for bonding and arousal pathways.
Sexual-health peptides act on central arousal and reproductive-hormone pathways rather than the vascular route of common ED drugs. PT-141 (bremelanotide) is the most-studied — a melanocortin agonist researched for libido in both sexes, with an approved prescription form existing for one indication. Kisspeptin is studied for upstream reproductive-hormone signaling, and Oxytocin for bonding and arousal. Evidence is graded below.
⚠ Research & educational use only — not medical adviceMost-studied compounds for sexual health & libido
Each links to a full research protocol with reconstitution steps, research dose ranges reported in the literature, and an honest evidence grade. Ranked roughly by depth of supporting research.
PT-141
MelanocortinBremelanotide — a melanocortin agonist studied for libido and arousal pathways acting centrally rather than vascularly.
View protocol →Bremelanotide
MelanocortinThe full name for PT-141; researched for sexual-desire pathways in both sexes.
View protocol →Kisspeptin
ReproductiveA peptide studied for stimulating the reproductive-hormone axis (GnRH/LH/FSH signaling).
View protocol →Oxytocin
BondingResearched for social bonding, trust and arousal-related pathways.
View protocol →Melanotan II
MelanocortinA melanocortin agonist studied for pigmentation and, secondarily, libido pathways; notable side-effect profile in research.
View protocol →Sourcing these compounds for research
Researchers studying the molecules above source cGMP-tested material from our official sponsor, LiveWell Peptides. All compounds are sold strictly for laboratory research use.
Source at LiveWell Peptides →Preferred vendor. For research use only. Not for human consumption. Not medical advice.
Plan your research
Free tools to take any compound above from vial to a documented protocol.
Frequently asked questions
- How is PT-141 different from common ED medications?
- PT-141 (bremelanotide) acts on central melanocortin pathways linked to desire, whereas common ED drugs act on blood flow. They are studied for different parts of the response. A prescription form of bremelanotide exists for one specific indication.
- Are these peptides legal and FDA-approved?
- Most research peptides discussed here are not FDA-approved for human use and are sold strictly for laboratory research purposes. A few molecules (such as certain GLP-1 receptor agonists) exist in approved prescription forms, but the research-grade material referenced on this site is not the same as a prescription product. Always consult a licensed healthcare provider before making any health decision.
- How strong is the research behind these?
- It varies by compound. Some — like the GLP-1 agonists — have large human clinical trials; others (such as BPC-157 or Epithalon) rest mainly on animal and in-vitro data with limited human studies. Each protocol page on this site grades the evidence so you can see exactly what is well-supported versus preliminary.